|
Dallas–Fort Worth, TX Press Releases
|
(Dallas.CityRegions.Com, January 08, 2015 ) Dallas, TX -- Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014: Order report by calling Rnrmarketsresearch.com at +1 888 391 5441 OR send an email on sales@rnrmarketresearch.com with your contact details.
“Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014″ provides data on the Retinopathy Of Prematurity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinopathy Of Prematurity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinopathy Of Prematurity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Complete report available at http://www.rnrmarketresearch.com/retinopathy-of-prematurity-global-clinical-trials-review-h2-2014-market-report.html
Scope
• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Inquire for discount on this report @ http://www.rnrmarketresearch.com/contacts/discount?rname=255061 (Single User License US$2500)
List of Tables
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Region, 2014* 7
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Retinopathy Of Prematurity Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Retinopathy Of Prematurity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Retinopathy Of Prematurity Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Retinopathy Of Prematurity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Retinopathy Of Prematurity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, G7 Countries (%), 2014* 15
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Retinopathy Of Prematurity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Retinopathy Of Prematurity to Ophthalmology Clinical Trials, E7 Countries (%), 2014* 18
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Retinopathy Of Prematurity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Retinopathy Of Prematurity Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Retinopathy Of Prematurity Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Buy a Copy of the report at http://www.rnrmarketresearch.com/contacts/purchase?rname=255061
For more information on Life Sciences Market Contact sales@rnrmarketresearch.com / Call +1 888 391 5441 for further information on “Retinopathy Of Prematurity Global Clinical Trials Review, H2, 2014” report OR for any other market research and intelligence needs you may have for your business.
RnR Market Research
Ritesh Tiwari
18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com
|
|
|
|